Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Exchange Rate Effect (2023 - 2025)

Historic Exchange Rate Effect for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to $7.8 million.

  • Immunocore Holdings' Exchange Rate Effect fell 3636.14% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.1 million, marking a year-over-year decrease of 3180.46%. This contributed to the annual value of -$1.7 million for FY2024, which is 12059.57% down from last year.
  • Immunocore Holdings' Exchange Rate Effect amounted to $7.8 million in Q3 2025, which was down 3636.14% from $11.9 million recorded in Q2 2025.
  • Immunocore Holdings' Exchange Rate Effect's 5-year high stood at $12.3 million during Q3 2024, with a 5-year trough of -$38.4 million in Q4 2022.
  • For the 5-year period, Immunocore Holdings' Exchange Rate Effect averaged around -$224857.1, with its median value being $1.4 million (2021).
  • As far as peak fluctuations go, Immunocore Holdings' Exchange Rate Effect crashed by 656981.45% in 2022, and later soared by 756415.09% in 2025.
  • Quarter analysis of 5 years shows Immunocore Holdings' Exchange Rate Effect stood at $593000.0 in 2021, then tumbled by 6569.81% to -$38.4 million in 2022, then surged by 128.11% to $10.8 million in 2023, then tumbled by 220.86% to -$13.0 million in 2024, then surged by 159.98% to $7.8 million in 2025.
  • Its Exchange Rate Effect stands at $7.8 million for Q3 2025, versus $11.9 million for Q2 2025 and $8.4 million for Q1 2025.